The Child with Endocrine Dysfunction
ENDOCRINE SYSTEM
Functionality: Controls and regulates metabolism.
Distribution of Endocrine Glands:
- Hypothalamus
- Pineal gland
- Pituitary gland
- Thyroid gland
- Parathyroid glands
- Thymus
- Adrenal glands
- Pancreas
- Ovaries
- TestesConnection to Other Systems:
- The hypothalamus is the link between the autonomic nervous system (ANS) and the endocrine system.System Components:
- Sender Cells: Cells that send chemical messages using hormones.
- Target Cells/Organs: Organs that receive chemical messages (e.g., liver, kidneys, thyroid, gonads).
- Transport Medium: The environment through which chemicals are transported from the site of synthesis to the site of cellular action.
- Hormone Definition: A chemical substance that exerts a physiologic controlling effect on other cells.
- Feedback Control: Mechanisms of hormone production and secretion can be either positive or negative.
ENDOCRINE SYSTEM OVERVIEW
Hormones from Anterior Pituitary:
- Growth hormone (GH)
- Adrenocorticotropic hormone (ACTH)
- Thyroid-stimulating hormone (TSH)
- Gonadotropic hormones (FSH and LH)
- Prolactin (PRL)
- Melanocyte-stimulating hormone (MSH)Target Organs:
- Mammary glands, adrenal cortex, thyroid, gonads, skin, kidneys, uterus.
PITUITARY GLAND
Overview: Responsible for regulating many other glands; consists of two lobes with unique functions:
- Anterior Lobe (Adenohypophysis):
- Known as the "master gland"; regulated by hypothalamic hormones.
- Posterior Lobe (Neurohypophysis):
- Different hormones are secreted compared to the anterior lobe.
HORMONES AND FUNCTIONS
Anterior Pituitary Hormones
Thyrotropin (TSH): Stimulates thyroid gland.
Growth Hormone (GH): Increases blood glucose levels and promotes overall growth.
Corticotropin (ACTH): Promotes secretion from adrenal cortex.
Follicle-stimulating hormone (FSH) and Luteinizing hormone (LH): Affect gonadal function.
Prolactin (PRL): Stimulates mammary gland function.
Posterior Pituitary Hormones
Oxytocin:
- Functions: Uterine contractions, milk letdown, orgasm facilitation, social recognition:
- Dysfunction results in issues like benign prostatic hyperplasia in males and absence of milk letdown in females.Vasopressin (ADH):
- Functions: Water conservation, electrolyte balance, blood vessel constriction; dysfunction can lead to Diabetes Insipidus.
- Dysfunction Details: Under secretion results in excessive urination and thirst.
KEY POINTS OF ENDOCRINE SYSTEM
Immature at birth; hormonal secretion varies throughout the day.
Regulates activity of cells and organs for growth and metabolism.
Maintains homeostasis via connections between ANS and the pituitary gland.
Feedback mechanisms regulate the system (positive and negative).
Diagnosis often requires laboratory tests and imaging.
PRECOCIOUS PUBERTY
Definition: Early sexual development marked by the appearance of secondary sex characteristics.
Boys: Before age 9; Girls: Before age 8 (90% idiopathic).
Consequences: Accelerated bone growth and early fusion of growth plates, potentially leading to reduced adult height.
Therapeutic Management:
- Objective: Preserve adult health and reverse premature secondary sex characteristics.
- Treatment includes monthly synthetic LHRH (subcutaneous).
- Considerations include risk of sexual abuse, teasing, and family support.
DIABETES INSIPIDUS
Description: Principal disorder of the posterior pituitary; arises from dysfunction or under secretion of ADH.
Types: Nephrogenic vs. central DI.
Symptoms: Polyuria and polydipsia (insatiable thirst, excessive urination).
Diagnostic Evaluation: Water deprivation test (monitor dehydration).
Management:
- DDAVP (synthetic vasopressin, intranasal), monitor for dilutional hyponatremia.
- Fluid restriction aimed at balancing fluids.
- Nursing Management: Family education and monitoring urine specific gravity.
SYNDROME OF INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION (SIADH)
Resulting from hypersecretion of ADH, leading to inability to excrete free water.
Etiology includes infection, hydrocephalus, or brain tumors.
Symptoms: Fluid retention, hypotonicity, possibly stupor and seizures.
Diagnostic Criteria: Low urine output, Na < 135mmol/L, high urine specific gravity.
Management: Correcting the underlying cause, achieving fluid balance, and careful hyponatremia correction.
- Important monitoring including weight, neurological checks, and Na levels.
DIABETES INSIPIDUS vs SIADH
Diabetes Insipidus (High and Dry)
Symptoms Include: Increased urination (polyuria), nocturia, increased thirst (polydipsia), hypernatremia, low urine specific gravity < 1.005, elevated serum osmolality > 300 mOsm/kg.
SIADH (Low and Wet)
Symptoms Include: Decreased urination, excessive thirst, fluid retention, hypertension, hyponatremia < 125 mEq/L, high urine specific gravity > 1.030, decreased serum osmolality < 280 mOsm/kg.
GROWTH HORMONE DEFICIENCY
Description: Insufficient production or secretion of GH, leading to poor growth and short stature.
Causes: Isolated or could be secondary to brain tumors or congenital issues.
Management: Growth hormone replacement, preferably administered at night via injection. Family education about the disorder and GH administration is essential.
DIAGNOSTICS FOR ENDOCRINE FUNCTION
Laboratory Tests: Serum hormone levels and stimulation tests.
Bone Age Scan: X-ray of the left wrist; indicators of ossified bones help assess delay or precocious ossification.
THYROID FUNCTION
Functions: Regulates basal metabolic rate (BMR), growth, tissue differentiation.
Hormone Types Produced:
- Thyroxine (T4)
- Triiodothyronine (T3)
- Calcitonin
HYPOTHYROIDISM vs HYPERTHYROIDISM
Hypothyroidism Symptoms:
Dry hair, hair loss, cold intolerance, weight gain, slow heartbeat, goiter, constipation.
Clinical consequences may include infertility and risks of miscarriage.
Hyperthyroidism Symptoms:
Bulging eyes, puffy face, heat intolerance, rapid heartbeat, weight loss, diarrhea.
Clinical consequences may include irregular menstrual cycles.
JUVENILE HYPOTHYROIDISM
Types: Congenital (screened at birth) and acquired.
Symptoms: Puffiness, constipation, lethargy, and poor feeding in infants.
Management: Skin care, administration of thyroxine therapy (e.g., Synthroid), use of stool softeners for constipation.
LYMPHOCYTIC THYROIDITIS (Hashimoto's Disease)
Most common thyroiditis in children and adolescents.
Symptoms: Signs of hypothyroidism; treatment revolves around management of symptoms.
HYPERTHYROIDISM (Graves Disease)
Clinical manifestations include exophthalmos and thyroid storms; requires careful therapeutic management:
- Medications: Antithyroid drugs (e.g., Tapazole) with monitoring for infection risks.
- Possible surgical interventions (subtotal thyroidectomy or radioiodine ablation).
GOITER
Description: Hypertrophy/enlargement of the thyroid gland.
Types: Congenital and acquired.
Symptoms: Enlarged thyroid gland; management involves symptom alleviation and normalization of thyroid levels.
THYROTOXICOSIS
Definition: Crisis state caused by sudden hormone release; can be life-threatening.
Management: Antithyroid drugs, beta-blockers; nursing focus on maintaining homeostasis and monitoring vitals.
HYPERPARATHYROIDISM
Causes: Primary or secondary (e.g., renal disease).
Management strategies will vary based on etiology; nursing focus on patient care and education.
DISORDERS OF ADRENAL FUNCTION
Include: Acute adrenal insufficiency, Addison Disease, Cushing syndrome, congenital adrenal hyperplasia, pheochromocytoma.
ADDISON DISEASE (Primary Adrenal Insufficiency)
Rare in children; symptoms include hyperkalemia and hyponatremia.
Management: Replacement of glucocorticoids and mineralocorticoids.
CUSHING SYNDROME
Cause: Excess circulating cortisol.
Signs: Cushingoid features, hypertension, immunocompromise.
Management: Varies based on root causes; encompassing nursing care.
CONGENITAL ADRENAL HYPERPLASIA
Cause: Reduced enzyme activity leading to high ACTH levels and virilization symptoms.
Management: Glucocorticoids, mineralocorticoids, sodium supplementation, and monitoring during stress.
PHEOCHROMOCYTOMA
Rare catecholamine-secreting tumor; diagnosed via imaging (CT, MRI); managed with surgical intervention.
DIABETES MELLITUS (DM)
Type 1 DM: Peaks in early childhood/adolescence; destruction of pancreatic beta cells leading to insulin deficiency.
- Diagnostic criteria: HgA1C > 6.5%, random glucose > 200 mg/dL.Type 2 DM: Related to insulin resistance; incidence rising with obesity.
- Diagnostic criteria: Elevated glucose > 160 mg/dL (fasting) or > 200 mg/dL (random).
TYPE 1 DM PATHOPHYSIOLOGY:
In fasting: Fat/protein mobilization, liver converts fats to ketones.
Post-meal: Pancreas secretes insulin for glucose regulation.
DIABETES MELLITUS TYPE 1: DIABETIC KETOACIDOSIS (DKA)
Description: Inability to utilize ketones due to insulin deficiency.
Manifestations: Hyperglycemia, acidosis, polyuria.
Management Protocol: Prioritize hydration, monitor cardiorespiratory status, administer insulin post-rehydration, monitor electrolytes and urine for ketones.
DKA PATHOPHYSIOLOGY:
Insulin deficiency leads to impaired metabolism of fats, proteins, and carbohydrates; cellular starvation occurs.
NURSING CLINICAL PEARL:
"Cool and clammy, give some candy"—if the diagnosis between hypoglycemia and hyperglycemia is uncertain, treat as hypoglycemia first by administering carbs.
LONG-TERM COMPLICATIONS OF DM:
Effects of hyperglycemia on vascular system (retinopathy, nephropathy, neuropathy, cardiovascular disease).
Management: Comprehensive approach with insulin therapy, nutrition management, and responsible monitoring.
- Emphasize importance of continuous education and involvement of a diabetes nurse educator.